Carl Dambkowski, the Chief Medical Officer of $APGE, sold 2,481 shares of the company on 02-04-2026 for an estimated $160,967. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares of this class of stock. Following this trade, they now own 214,167 shares of this class of $APGE stock.
$APGE Insider Trading Activity
$APGE insiders have traded $APGE stock on the open market 43 times in the past 6 months. Of those trades, 0 have been purchases and 43 have been sales.
Here’s a breakdown of recent trading of $APGE stock by insiders over the last 6 months:
- FUNDS MANAGEMENT LLC FAIRMOUNT sold 1,750,000 shares for an estimated $133,525,000
- MICHAEL THOMAS HENDERSON (Chief Executive Officer) has made 0 purchases and 14 sales selling 100,000 shares for an estimated $7,390,451.
- CARL DAMBKOWSKI (Chief Medical Officer) has made 0 purchases and 17 sales selling 53,720 shares for an estimated $3,535,452.
- JANE HENDERSON (Chief Financial Officer) has made 0 purchases and 11 sales selling 17,500 shares for an estimated $1,268,275.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APGE Hedge Fund Activity
We have seen 94 institutional investors add shares of $APGE stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 1,230,377 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $48,882,878
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,055,464 shares (-81.8%) from their portfolio in Q3 2025, for an estimated $41,933,584
- WELLINGTON MANAGEMENT GROUP LLP added 917,991 shares (+24.1%) to their portfolio in Q3 2025, for an estimated $36,471,782
- WOODLINE PARTNERS LP removed 812,887 shares (-93.4%) from their portfolio in Q3 2025, for an estimated $32,296,000
- CITADEL ADVISORS LLC added 673,585 shares (+135.9%) to their portfolio in Q3 2025, for an estimated $26,761,532
- VANGUARD GROUP INC added 612,193 shares (+27.3%) to their portfolio in Q4 2025, for an estimated $46,208,327
- SIREN, L.L.C. removed 594,994 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $23,639,111
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$APGE Analyst Ratings
Wall Street analysts have issued reports on $APGE in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/06/2026
- Stephens & Co. issued a "Overweight" rating on 12/17/2025
- Deutsche Bank issued a "Buy" rating on 12/10/2025
- Craig-Hallum issued a "Buy" rating on 11/03/2025
- Mizuho issued a "Outperform" rating on 10/21/2025
- RBC Capital issued a "Outperform" rating on 09/25/2025
- B of A Securities issued a "Buy" rating on 08/28/2025
To track analyst ratings and price targets for $APGE, check out Quiver Quantitative's $APGE forecast page.
$APGE Price Targets
Multiple analysts have issued price targets for $APGE recently. We have seen 7 analysts offer price targets for $APGE in the last 6 months, with a median target of $103.0.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $83.0 on 01/22/2026
- Julian Harrison from BTIG set a target price of $137.0 on 01/06/2026
- Sudan Loganathan from Stephens & Co. set a target price of $95.0 on 12/17/2025
- David Hoang from Deutsche Bank set a target price of $103.0 on 12/10/2025
- Adam Vogel from Craig-Hallum set a target price of $109.0 on 11/03/2025
- Joseph Catanzaro from Mizuho set a target price of $105.0 on 10/21/2025
- Tim Anderson from B of A Securities set a target price of $87.0 on 08/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
